PRIVAPATH DIAGNOSTICS LIMITED

Privapath Diagnostics Limited specialises in in-vitro diagnostic (IVD) specimen collection kits designed for home use. These include capillary blood collection kits, urine specimen collection kits, faecal specimen collection kits, and oral/upper respiratory tract specimen collection kits. The devices are intended for self-collection of biological samples, such as blood, urine, faeces, and throat swabs, to simplify sample collection outside clinical settings while maintaining sterility and usability.

Privapath Diagnostics Limited is based in Ireland. This location means its devices comply with EU medical device regulations, including classification under EU directives. The company’s products are listed in the EU’s EUDAMED database, ensuring traceability and adherence to European regulatory standards. Additionally, some of its devices are also included in the FDA’s Unique Device Identifier (UDI) system, reflecting compliance with U.S. requirements.

Privapath Diagnostics Limited’s devices are listed in two key regulatory registries: the EU’s EUDAMED database and the FDA’s Unique Device Identifier (UDI) system. These registries ensure transparency, traceability, and compliance with both European and U.S. medical device regulations. Listing in these systems helps healthcare providers and regulators verify the authorised status of specific devices.

Privapath Diagnostics Limited’s devices are classified under EU regulations as Class A, Class I, Class II, and Class N. The classification depends on the risk associated with each product—lower-risk items like general specimen collection kits fall into Class A or Class I, while higher-risk or invasive devices may fall into Class II. Class N applies to certain IVDs with specific regulatory pathways. This classification determines the level of regulatory oversight and requirements for each device.